[Federal Register Volume 76, Number 4 (Thursday, January 6, 2011)]
[Notices]
[Pages 787-788]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-26]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Breast Cancer in Young Women (ACBCYW)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

Times and Dates

    9 a.m.-5 p.m., January 31, 2011.
    8 a.m.-3 p.m., February 1, 2011.
    Place: Emory Conference Center Hotel and Emory Inn, 1615 Clifton 
Road, NE., Atlanta, Georgia 30329.
    Status: Open to the public, limited only by the space available.

[[Page 788]]

    Purpose: The committee provides advice and guidance to the 
Secretary, HHS; the Assistant Secretary for Health; and the Director, 
CDC, regarding the formative research, development, implementation and 
evaluation of evidence-based activities designed to prevent breast 
cancer (particularly among those at heightened risk) and promote the 
early detection and support of young women who develop the disease. The 
advice provided by the Committee will assist in ensuring scientific 
quality, timeliness, utility, and dissemination of credible appropriate 
messages and resource materials.
    Matters To Be Discussed: The agenda will include discussions on 
evidence-based recommendations and the public health aspects of breast 
cancer in young women including biology, genomics, prevention, early 
diagnosis, treatment, and survivorship; appropriate venues to educate 
women at increased risk for developing breast cancer at younger ages; 
and approaches to increase awareness of clinicians/practitioners 
regarding topics such as breast health, symptoms, diagnosis, and 
treatment of breast cancer in young women.
    Agenda items are subject to change as priorities dictate.
    In order to assure that sufficient space and materials are 
available for meeting attendees, CDC is requesting that potential 
attendees register to attend this meeting at the following Web site: 
http://www.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm.
    Contact Person for More Information: Temeika L. Fairley, PhD, 
Designated Federal Officer, National Center for Chronic Disease 
Prevention and Health Promotion, CDC, 5770 Buford Hwy, NE., Mailstop 
K52, Atlanta, Georgia, 30341, Telephone (770) 488-4518, Fax (770) 488-
4760.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and Agency for 
Toxic Substances and Disease Registry.

    Dated: December 28, 2010.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-26 Filed 1-5-11; 8:45 am]
BILLING CODE 4163-18-P